Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens

Prostate

Volumn 74, Issue 6, 2014, Pages 680-687

  Kimura, Kyosuke ^a   Tsuzuki, Toyonori ^b   Kato, Masashi ^c   Saito, Akiko M ^a   Sassa, Naoto ^c   Ishida, Ryo ^b   Hirabayashi, Hiroki ^d   Yoshino, Yasushi ^c   Hattori, Ryohei ^e   Gotoh, Momokazu ^c  

^a NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^b NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

^c NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d KOMAKI CITY HOSPITAL   (Japan)

^e JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

cancer specific survival; clinical outcome; clinical progression free survival; intraductal carcinoma of the prostate; prostate cancer; radical prostatectomy

Indexed keywords

BICALUTAMIDE; GOSERELIN; LEUPRORELIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SPECIFIC SURVIVAL; CANCER SURGERY; DISEASE SEVERITY; FOLLOW UP; GLEASON SCORE; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; INTRADUCTAL CARCINOMA; INTRADUCTAL CARCINOMA OF THE PROSTATE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CARCINOMA; PROSTATECTOMY; RETROSPECTIVE STUDY; TREATMENT FAILURE; TUMOR INVASION; VERY ELDERLY;

CANCER-SPECIFIC SURVIVAL; CLINICAL OUTCOME; CLINICAL PROGRESSION-FREE SURVIVAL; INTRADUCTAL CARCINOMA OF THE PROSTATE; PROSTATE CANCER; RADICAL PROSTATECTOMY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84897024396     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.22786     Document Type: Article

References (31)

1. Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, Nordling S, Haggman M, Andersson SO, Bratell S, Spangberg A, Palmgren J, Steineck G, Adami HO, Johansson JE,. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011; 364: 1708-1717.
2. Roder MA, Brasso K, Christensen IJ, Johansen J, Langkilde NC, Hvarness H, Carlsson S, Jakobsen H, Borre M, Iversen P,. Survival after radical prostatectomy for clinically localised prostate cancer: A population-based study. BJU Int 2013.
3. Porter CR, Suardi N, Capitanio U, Hutterer GC, Kodama K, Gibbons RP, Correa R Jr, Perrotte P, Montorsi F, Karakiewicz P,. A nomogram predicting prostate cancer-specific mortality after radical prostatectomy. Urol Int 2010; 84: 132-140.
4. Meurs P, Galvin R, Fanning DM, Fahey T,. Prognostic value of the CAPRA clinical prediction rule: A systematic review and meta-analysis. BJU Int 2013; 111: 427-436.
5. Oefelein MG, Smith N, Carter M, Dalton D, Schaeffer A,. The incidence of prostate cancer progression with undetectable serum prostate specific antigen in a series of 394 radical prostatectomies. J Urol 1996; 154: 2128-2131.
6. Collette L,. Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials. Eur Urol 2008; 53: 6-9.
7. Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L,. Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: Long-term results of a randomised controlled trial (EORTC trial 22911). Lancet 2012; 380: 2018-2027.
8. Kovi J, Jackson MA, Heshmat MY,. Ductal spread in prostatic carcinoma. Cancer 1985; 56: 1566-1573.
9. McNeal JE, Yemoto CE,. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol 1996; 20: 802-814.
10. Wilcox G, Soh S, Chakraborty S, Scardino PT, Wheeler TM,. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum Pathol 1998; 29: 1119-1123.
11. Rubin MA, de La Taille A, Bagiella E, Olsson CA, O'Toole KM,. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: Incidence and clinical implications. Am J Surg Pathol 1998; 22: 840-848.
12. Cohen RJ, McNeal JE, Baillie T,. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: Significance for cancer progression. Prostate 2000; 43: 11-19.
13. Efstathiou E, Abrahams NA, Tibbs RF, Wang X, Pettaway CA, Pisters LL, Mathew PF, Do KA, Logothetis CJ, Troncoso P,. Morphologic characterization of preoperatively treated prostate cancer: Toward a post-therapy histologic classification. Eur Urol 2010; 57: 1030-1038.
14. D'Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA, Tomaszewski JE, Renshaw AA, Kaplan I, Beard CJ, Wein A,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-974.
15. Sobin LH, Gospodarowicz MK, Wittekind C,. TNM classification of malignant tumours, 7th edition. Oxford UK: Blackwell publishing Ltd; 2009.
16. Epstein JI, Allsbrook WC Jr, Amin MB, Egevad LL,. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005; 29: 1228-1242.
17. Rhamy RK, Buchanan RD, Spalding MJ,. Intraductal carcinoma of the prostate gland. J Urol 1973; 109: 457-460.
18. McNeal JE, Reese JH, Redwine EA, Freiha FS, Stamey TA,. Cribriform adenocarcinoma of the prostate. Cancer 1986; 58: 1714-1719.
19. Dawkins HJ, Sellner LN, Turbett GR, Thompson CA, Redmond SL, McNeal JE, Cohen RJ,. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Prostate 2000; 44: 265-270.
20. O'Brien BA, Cohen RJ, Wheeler TM, Moorin RE,. A post-radical- prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis. BJU Int 2011; 107: 389-395.
21. Bonkhoff H, Wheeler TM, van der Kwast TH, Magi-Galluzzi C, Montironi R, Cohen RJ,. Intraductal carcinoma of the prostate: Precursor or aggressive phenotype of prostate cancer ? Prostate 2013; 73: 442-448.
22. Lotan TL, Gurel B, Sutcliffe S, Esopi D, Liu W, Xu J, Hicks JL, Park BH, Humphreys E, Partin AW, Han M, Netto GJ, Isaacs WB, De Marzo AM,. PTEN protein loss by immunostaining: Analytic validation and prognostic indicator for a high risk surgical cohort of prostate cancer patients. Clin Cancer Res 2011; 17: 6563-6573.
23. Eggener SE, Scardino PT, Walsh PC, Han M, Partin AW, Trock BJ, Feng Z, Wood DP, Eastham JA, Yossepowitch O, Rabah DM, Kattan MW, Yu C, Klein EA, Stephenson AJ,. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011; 185: 869-875.
24. Chalfin HJ, Dinizo M, Trock BJ, Feng Z, Partin AW, Walsh PC, Humphreys E, Han M,. Impact of surgical margin status on prostate-cancer-specific mortality. BJU Int 2012; 110: 1684-1689.
25. Mauermann J, Fradet V, Lacombe L, Dujardin T, Tiguert R, Tetu B, Fradet Y,. The Impact of solitary and multiple positive surgical margins on hard clinical end points in 1712 adjuvant treatment-naive pT 2-4 N0 radical prostatectomy patients. Eur Urol 2013; 64: 19-25.
26. Dong F, Wang C, Farris AB, Wu S, Lee H, Olumi AF, McDougal WS, Young RH, Wu CL,. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system. Am J Surg Pathol 2012; 36: 838-843.
27. Kuroiwa K, Shiraishi T, Naito S,. Gleason score correlation between biopsy and prostatectomy specimens and prediction of high-grade Gleason patterns: Significance of central pathologic review. Urology 2011; 77: 407-411.
28. Wilt TJ, Brawer MK, Jones KM, Barry MJ, Aronson WJ, Fox S, Gingrich JR, Wei JT, Gilhooly P, Grob BM, Nsouli I, Iyer P, Cartagena R, Snider G, Roehrborn C, Sharifi R, Blank W, Pandya P, Andriole GL, Culkin D, Wheeler T,. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012; 367: 203-213.
29. Guo CC, Epstein JI,. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance. Mod Pathol 2006; 19: 1528-1535.
30. Yossepowitch O, Bjartell A, Eastham JA, Graefen M, Guillonneau BD, Karakiewicz PI, Montironi R, Montorsi F,. Positive surgical margins in radical prostatectomy: Outlining the problem and its long-term consequences. Eur Urol 2009; 55: 87-99.
31. Tollefson MK, Karnes RJ, Rangel LJ, Bergstralh EJ, Boorjian SA,. The impact of clinical stage on prostate cancer survival following radical prostatectomy. J Urol 2013; 189: 1707-1712.